Garetosmab (REGN-2477) — Research Compounds Library | RetatrutideCompare

Fully human monoclonal antibody against activin A developed by Regeneron for fibrodysplasia ossificans progressiva (FOP). Phase 2 LUMINA-1 trial showed marked reduction in new heterotopic ossification.